#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Italy Spain

  • Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria

  • Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of Atezolizumab, Carboplatin, and Etoposide with or Without Tiragolumab for Patients with Untreated Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece Italy Poland

  • Study on Pembrolizumab, Etoposide, and Cisplatin or Carboplatin for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Hungary Italy Poland Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Hungary

  • Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark